SPEAKER – From nutrition to therapy: Commercialising the therapeutic potential of the microbiome in the field of metabolism
15 February @ 09.25
PANELLIST – THE BIG DEBATE: Where are the growth opportunities in the microbiome, probiotics and prebiotics?
15 February @ 12.30
Appointed as CEO in 2018, Georges has led a business model transformation at LNC from nutrition towards biotechnologies and drug-based therapeutics. A microbiologist by training, he has worked extensively in healthcare management and business development for pharmaceutical giants such as Cellectis, Galapagos, ProStrakan, Sanofi-Aventis and Celyad. He has a PhD in Microbiology from Pierre and Marie Curie University and a Masters in Management and Strategy from ESSEC Business School, both in Paris, France.